Twenty-year follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia.

Publication Type:

Journal Article


Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, Volume 11, Issue 10, p.814-5 (2005)


Bone Marrow Transplantation, Cyclosporine, Drug Therapy, Combination, Follow-Up Studies, Graft vs Host Disease, Histocompatibility Testing, Humans, LEUKEMIA, methotrexate, Premedication, Prevalence, Survival Analysis